| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 65, 697-702, Copyright © 1987 by Endocrine Society
ARTICLES |
L Nilas and C Christiansen
Department of Clinical Chemistry, University of Copenhagen, Glostrup Hospital, Denmark.
To examine the influence of age and the menopause on bone loss we studied 178 healthy women, aged 29-78 yr. Bone mass was measured at 2 forearm sites, in the total spine, in the lumbar spine, and in the whole body by single and dual photon absorptiometry. Women of the same age but different menopausal status had significantly different bone masses, whereas a 5-yr difference in age had no effect on bone mass in women with the same menopausal status. At the menopause the hormone changes (low serum estrogen and high serum gonadotropin levels) occurred simultaneously with the appearance of biochemical indices of increased bone turnover. Neither biochemical values nor bone measurements indicated significant bone loss before the menopause. We conclude that the menopause has a greater effect on bone loss than does chronological age.
This article has been cited by other articles:
![]() |
M. R. Sowers, M. Jannausch, D. McConnell, R. Little, G. A. Greendale, J. S. Finkelstein, R. M. Neer, J. Johnston, and B. Ettinger Hormone Predictors of Bone Mineral Density Changes during the Menopausal Transition J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1261 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Newcomb, A. Trentham-Dietz, K. M. Egan, L. Titus-Ernstoff, J. A. Baron, B. E. Storer, W. C. Willett, and M. J. Stampfer Fracture History and Risk of Breast and Endometrial Cancer Am. J. Epidemiol., June 1, 2001; 153(11): 1071 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. O'Flaherty Modeling Normal Aging Bone Loss, with Consideration of Bone Loss in Osteoporosis Toxicol. Sci., May 1, 2000; 55(1): 171 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gori, L. C. Hofbauer, C. A. Conover, and S. Khosla Effects of Androgens on the Insulin-Like Growth Factor System in an Androgen-Responsive Human Osteoblastic Cell Line Endocrinology, December 1, 1999; 140(12): 5579 - 5586. [Abstract] [Full Text] |
||||
![]() |
R. R. Recker, K. M. Davies, R. M. Dowd, and R. P. Heaney The Effect of Low-Dose Continuous Estrogen and Progesterone Therapy with Calcium and Vitamin D on Bone in Elderly Women: A Randomized, Controlled Trial Ann Intern Med, June 1, 1999; 130(11): 897 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Michaëlsson, J. A Baron, B. Y Farahmand, O. Johnell, C. Magnusson, P.-G. Persson, I. Persson, and S. Ljunghall Hormone replacement therapy and risk of hip fracture: population based case-control study BMJ, June 20, 1998; 316(7148): 1858 - 1863. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |